Events | Melius Pharma AB

top of page

Home
Diseases
Pipeline
About
Contact
News
More

Use tab to navigate through the menu items.

No events at the moment

Melius Pharma is a Swedish clinical-stage pharmaceutical company. We develop new treatments for chronic cough in Idiopathic Pulmonary Fibrosis (IPF).

Registered address:

MELIUS PHARMA AB, Stockholmsvägen 45c, 182 78 STOCKSUND. Sweden

Intellectual Property

Patent application covering the use of ME-015 for treatment of cough associated with interstitial lung diseases has been filed with priority from 23.12.2015

European patent granted on 20 January 2021
US patent in the process of being approved

Formulation patent filed with priority from 29.08.2017 and in national phase (EPO, US, KR, CN, CA, AU, IN).

Home
Diseases
Pipeline
About
Contact
News
More

Use tab to navigate through the menu items.

Cookie Policy

Privacy Notice

bottom of page